SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade

Tyrosine phosphatase SHP2 is a promising drug target in cancer immunotherapy due to its bidirectional role in both tumor growth promotion and T-cell inactivation. Its allosteric inhibitor SHP099 is known to inhibit cancer cell growth both in vitro and in vivo. However, whether SHP099-mediated SHP2 i...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingxia Zhao (Author), Wenjie Guo (Author), Yuanyuan Wu (Author), Chenxi Yang (Author), Liang Zhong (Author), Guoliang Deng (Author), Yuyu Zhu (Author), Wen Liu (Author), Yanhong Gu (Author), Yin Lu (Author), Lingdong Kong (Author), Xiangbao Meng (Author), Qiang Xu (Author), Yang Sun (Author)
Format: Book
Published: Elsevier, 2019-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available